Sofinnova Venture Partners IX, L.P.
CIK 1612133 · last filed 2020-06-03
Sofinnova Venture Partners IX, L.P. is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing shows the insider sold $3.2M of ITRM on Jun 3, 2020. Across all open-market trades the lifetime net is +$26.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.14M
2
2
$26.75M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Iterum Therapeutics plc (ITRM) Delisted | 10%+ Owner | 108,434 | $0.03 | $3.3K | -$3.25M | 1 | 2020-06-03 |
| NXTC | 10%+ Owner | 210,155 | $5.42 | $1.14M | $30.00M | 1 | 2019-05-15 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-03 | Iterum Therapeutics plc (ITRM) Delisted | Sell (S) | −2,000,000 | -$3.25M | EDGAR |
| 2019-05-15 | NXTC | Mixed | +12,609,280 | $30.00M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.